• Issue

    Psycho-Oncology: Volume 32, Issue 10

    1467-1627
    October 2023

ISSUE INFORMATION

Free Access

Issue Information

  • Pages: 1467-1468
  • First Published: 04 October 2023

REVIEWS

ORIGINAL ARTICLES

CLINICAL CORRESPONDENCE

Brief case report: A case of FOLFIRI—Induced psychosis

  • Pages: 1625-1627
  • First Published: 29 August 2023
Key points

  • Psychosis may occur due to the FOLFIRI chemotherapy regimen.

  • An exhaustive approach to confounding elements of a patient's medical history should be taken to rule out competing causes of psychosis.

  • Both 5-FU and Irinotecan may be implicated in psychosis, though which agent in particular is the cause is unclear.

  • Risperidone assisted in resolution of this patient's psychosis whilst Olanzapine and Quetiapine did not.

  • Both 5-FU and Irinotecan have pharmacologic traits that may induce changes in mental status.